GUGLIELMO, Alba
 Distribuzione geografica
Continente #
AS - Asia 1.219
NA - Nord America 853
EU - Europa 392
SA - Sud America 339
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.854
Nazione #
US - Stati Uniti d'America 805
SG - Singapore 444
IT - Italia 240
BR - Brasile 230
VN - Vietnam 179
CN - Cina 150
BD - Bangladesh 143
HK - Hong Kong 107
IN - India 46
AR - Argentina 37
JP - Giappone 33
FR - Francia 27
DE - Germania 25
ID - Indonesia 21
CA - Canada 20
CO - Colombia 16
EC - Ecuador 16
FI - Finlandia 16
GB - Regno Unito 16
IQ - Iraq 15
ZA - Sudafrica 15
CL - Cile 13
NL - Olanda 13
TR - Turchia 13
VE - Venezuela 13
PH - Filippine 12
MX - Messico 11
MA - Marocco 10
PK - Pakistan 10
PL - Polonia 9
SA - Arabia Saudita 9
UZ - Uzbekistan 9
ES - Italia 8
UA - Ucraina 8
TN - Tunisia 7
SE - Svezia 6
EG - Egitto 5
MY - Malesia 5
PE - Perù 5
HN - Honduras 4
JO - Giordania 4
PY - Paraguay 4
RU - Federazione Russa 4
AL - Albania 3
BE - Belgio 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
KE - Kenya 3
PT - Portogallo 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BH - Bahrain 2
BO - Bolivia 2
DZ - Algeria 2
GE - Georgia 2
GR - Grecia 2
KR - Corea 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
RO - Romania 2
RS - Serbia 2
AG - Antigua e Barbuda 1
AO - Angola 1
AU - Australia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BW - Botswana 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
ET - Etiopia 1
GT - Guatemala 1
HU - Ungheria 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
ML - Mali 1
MN - Mongolia 1
NA - Namibia 1
PS - Palestinian Territory 1
SD - Sudan 1
TH - Thailandia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.854
Città #
Singapore 234
San Jose 194
Ashburn 161
Hong Kong 107
Beijing 69
New York 68
Ho Chi Minh City 60
Council Bluffs 48
Hanoi 39
Los Angeles 30
Tokyo 30
Milan 29
São Paulo 29
Lauterbourg 19
Dallas 17
Chicago 15
Rome 15
Lappeenranta 12
Bologna 11
Buffalo 11
Brasília 10
Orem 10
Baghdad 9
Da Nang 9
Denver 9
Naples 9
Rio de Janeiro 9
Salt Lake City 9
Toronto 9
Warsaw 9
Belo Horizonte 8
Johannesburg 8
Quito 8
Dhaka 7
Haiphong 7
Lahore 7
Porto Alegre 7
Caracas 6
Chennai 6
Ferrara 6
Guayaquil 6
Houston 6
Stockholm 6
Tashkent 6
Ankara 5
Buenos Aires 5
Catania 5
Curitiba 5
Medellín 5
Mexico City 5
New Delhi 5
Phoenix 5
Riyadh 5
Salvador 5
San Francisco 5
Surabaya 5
Tampa 5
Turin 5
Bari 4
Bogotá 4
Brescia 4
Brooklyn 4
Delhi 4
Frankfurt am Main 4
Lima 4
Nha Trang 4
Santiago 4
Seattle 4
Thái Bình 4
Tunis 4
Amman 3
Atlanta 3
Berlin 3
Biên Hòa 3
Boardman 3
Campinas 3
Can Tho 3
Casablanca 3
Charlotte 3
Coventry 3
Fes 3
Florence 3
Frederick 3
Guarulhos 3
Hải Dương 3
Ipatinga 3
Juiz de Fora 3
Juneau 3
Kuala Lumpur 3
Manaus 3
Montreal 3
Mumbai 3
Nairobi 3
Nuremberg 3
Pavia 3
Phủ Lý 3
Piracicaba 3
Quận Chín 3
Thrissur 3
Agadir 2
Totale 1.591
Nome #
Multiple primary melanomas in Udine, northeastern Italy: a focus on epidemiology and new risk factors 92
Mycosis fungoides and IL-4/13 inhibitors: what is known and unmet needs 82
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders (SMPLPD), demographical, clinical, therapeutic and prognostic aspects: a retrospective monocentric analysis 81
Acral skin eruption observed during SARS‐CoV‐2 pandemic: possible keratolysis exfoliativa with red palms and soles 81
Biological therapy in patients with psoriasis: What we know about the effects on renal function 78
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results 75
The Italian Trend of Contact Allergy to 2- Hydroxyethyl Methacrylate: Is the Current European Legislation Working? 75
Head and neck dermatitis, a subtype of atopic dermatitis induced by Malassezia spp: Clinical aspects and treatment outcomes in adolescent and adult patients 71
Vulvar vitiligo and lichen sclerosus in children: A clinical challenge 70
Daily Patient's Relief From Pruritus and Sleep Disturbance Over One-Month Treatment with Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Multicenter Prospective Study 69
A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments 67
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective 66
Biologic treatment of psoriasis in solid organ transplant recipients 61
Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder nodule successfully treated with laser Co2 ablation: a case report and literature review 55
Bullous Wells Syndrome: a needle in the haystack 55
The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets 54
Atopic dermatitis and mycosis fungoides in a child: an overlooked association 54
Interleukin-13 inhibition and cancer risk: reply to Tang and Chen 52
Chilblains in a child with confirmed SARS-CoV-2 infection: a red flag for late-onset skin manifestation in previously infected individuals 52
Cutaneous adverse-events in patients treated with Ibrutinib 50
Unraveling the role of chemokines in cutaneous T-cell lymphoma: expression levels at different stages 50
A pink nodule on the left subscapular region in an 8-year-old girl 49
A Case of Bullous Rash Apparently Triggered by Meningococcal and Rotavirus Vaccines in an Infant: Focus on Infantile Bullous Pemphigoid 49
Bexarotene as maintenance treatment after therapies other than skin-directed therapy in advanced-stage mycosis fungoides: a pilot study 48
'Colouring' wipes phenomenon: a peculiar skin pigmentation induced by ascorbic acid observed during lockdown 48
Changes in emergency service access after spread of COVID-19 across Italy 47
Chilblain lesions after COVID-19 mRNA vaccine 46
BCL-2 expression in primary cutaneous follicle center lymphoma is associated with a higher risk of cutaneous relapses: A study of 126 cases 46
OX40–OX40L Axis in Cutaneous T-Cell Lymphomas: Pathogenic, Prognostic, and Potential Therapeutic Perspectives 46
Cutaneous squamous cell carcinoma progression during imiquimod treatment 46
Clinical and trichoscopic features in 18 cases of Folliculotropic Mycosis Fungoides with scalp involvement 44
Dermoscopy of chilblain-like lesions during the COVID-19 outbreak: A multicenter study on 10 patients 43
Development of Multiple Flat Warts During Treatment With Ruxolitinib 1.5% Cream for Non-Segmental Vitiligo: A Case Report 42
Eosinophilic Polymorphous Pruritic Eruption Associated With Radiotherapy: Clinical, Dermoscopic, and Histological Aspects 39
Violaceous Papules and Plaques on the Fingers during COVID-19: A Quiz 39
Seroconversion and neutralizing antibodies production after completion of Pfizer-BioNTech BNT 162b2 vaccination scheme among psoriatic patients receiving biological or topical treatment: A prospective observational cohort study 36
New insights into the oncological risk in heart transplant recipients: could skin tumors represent a marker of increased risk for solid neoplasm? 35
Terra firma-forme dermatosis: a systematic review 34
Erythroderma: psoriasis or lymphoma? A diagnostic challenge and therapeutic pitfall 34
Familial frontal fibrosing alopecia: the first Italian case 33
Guidelines for Vascular Anomalies by the Italian Society for the study of Vascular Anomalies (SISAV) 33
New insights on acral peeling dermatoses: An overlooked skin manifestation during COVID-19 pandemic 32
Ectopic hidradenitis suppurativa on the upper limbs in a Caucasian woman 32
Psoriasis and seronegative spondyloarthropathy in patients with atopic dermatitis treated with dupilumab or tralokinumab: a multicentre observational study 31
The microenvironment’s role in mycosis fungoides and sézary syndrome: From progression to therapeutic implications 31
Mogamulizumab-induced alopecia. Multicentric case series: Clinical, trichoscopic and histological characterization 31
Generalized granuloma annulare-like eruption secondary to acute Epstein–Barr virus infection 29
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome 29
Second neoplasm in cutaneous T-cell lymphoma patients: a marker of worse prognosis? 29
Erythroderma with brentuximab vedotin (skin side effects in mycosis fungoides) 29
Skin toxicities related to Bruton tyrosine kinase inhibitors: an updated review 28
Disseminate Recurrent Folliculitis and Hidradenitis Suppurativa Are Associated Conditions: Results From a Retrospective Study of 131 Patients With Down Syndrome and a Cohort of 12,351 Pediatric Controls 28
Primary cutaneous peripheral T-cell lymphoma not otherwise specified a rare and aggressive lymphoma 26
Iatrogenic Kaposi sarcoma during tumor necrosis factor alpha inhibitors 24
Reply to "Dermatoses caused by face mask wearing during the COVID-19 pandemic" 24
Estimating the incidence of COVID-19 skin manifestations on the general population in a territorial setting 24
Herpes zoster in COVID-19-positive patients 24
PTEN Hamartoma Tumor Syndrome: Skin Manifestations and Insights Into Their Molecular Pathogenesis 24
PD-1 and PD-L1 expression in mycosis fungoides and Sézary Syndrome 24
The red half-moon nail sign: a novel manifestation of coronavirus infection 23
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives 23
New insights into alopecia areata during COVID-19 pandemic: When infection or vaccination could play a role 23
Erythema nodosum: a clinical manifestation of Neisseria gonorrhoeae infection 22
Major cluster of paediatric ‘true’ primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown 22
Mycosis fungoides involving the genital area 21
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review 20
Chlormethine gel effectiveness as second-line treatment in mycosis fungoides: a single-centre retrospective study 20
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder (PCSM-LPD): Dermoscopic Clues to Address Its Diagnosis and Their Interobserver Reliability 18
“Nomen Omen: The Myth of God Janus” 18
Case Report of a Lymphocytic Variant HypereosinophilicSyndrome Mimicking T-Cell Lymphoma: A DiagnosticChallenge and Therapeutic Response to Mepolizumab 18
Oral pigmentation in children: a diagnostic challenge 18
Non-Melanoma Skin Cancer in Transplant Recipients: A Single-Centre Retrospective Cohort Study on the Role of Transplant Type, Immunosuppressive Exposure, and Tumor Subtypes 6
Totale 2.978
Categoria #
all - tutte 11.264
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.264


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025174 0 0 0 0 0 0 0 0 57 81 12 24
2025/20262.804 140 147 248 343 252 156 199 183 304 485 246 101
Totale 2.978